the Office information for the pre-
ceding year regarding—
‘‘(i) the number and type of 
seizures of drugs by each compo-
nent of the Department of Home-
land Security seizing drugs, as 
well as statistical information on 
the geographic areas of such sei-
zures; and 
‘‘(ii) the number of air and 
maritime patrol hours primarily 
dedicated to drug supply reduc-
tion missions undertaken by each 
component of the Department. 
‘‘(D) SECRETARY OF DEFENSE.—The 
Secretary of Defense shall, by July 1 
of each year, submit to the Director 
and the authorizing committees of 
Congress for the Office information 
for the preceding year regarding the 
number of air and maritime patrol 
hours primarily dedicated to drug 
supply 
reduction 
missions 
under-
taken by each component of the De-
partment of Defense.’’; and
(3) in subsection (b)(2)(B), by striking 
‘‘Program.’’ and inserting ‘‘Strategy.’’. 
SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to 
read as follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR 
DEVELOPMENT
AND SUBMISSION
OF NATIONAL 
DRUG CONTROL STRATEGY.—
‘‘(1) IN GENERAL.—Not later than Feb-
ruary 1 of each year, the President shall 
submit to Congress a National Drug Con-
trol Strategy, which shall set forth a com-
prehensive plan for reducing illicit drug 
use and the consequences of illicit drug 
use in the United States by reducing the 
demand for illegal drugs, limiting the 
availability of illegal drugs, and con-
ducting law enforcement activities with 
respect to illegal drugs. 
‘‘(2) CONTENTS.—
‘‘(A) IN
GENERAL.—The National 
Drug 
Control 
Strategy 
submitted 
under paragraph (1) shall include—
‘‘(i) comprehensive, research-
based, long-range, and quantifi-
able goals for reducing illicit drug 
use and the consequences of illicit 
drug use in the United States; 
‘‘(ii) annual objectives and 
strategy for demand reduction, 
supply reduction, and law en-
forcement activities, specific tar-
gets 
to 
accomplish 
long-range 
quantifiable reduction in illicit 
drug use as determined by the Di-
rector, and specific measurements 
to evaluate progress toward the 
targets and strategic goals; 
‘‘(iii) a strategy to reduce the 
availability and purity of illegal 
drugs and the level of drug-re-
lated crime in the United States; 
‘‘(iv) an assessment of Federal 
effectiveness in achieving the Na-
tional Drug Control Strategy for 
the previous year, including—
‘‘(I) a specific evaluation 
of whether the objectives and 
targets 
for 
reducing 
illicit 
drug use for the previous year 
were met and reasons for the 
success or failure of the pre-
vious year’s Strategy; and 
‘‘(II) an assessment of the 
availability and purity of ille-
gal drugs and the level of 
drug-related 
crime 
in 
the 
United States; 
‘‘(v) notification of any pro-
gram or budget priorities that the 
Director expects to significantly 
change from the current Strategy 
over the next five years; 
‘‘(vi) a review of international, 
State, local, and private sector 
drug control activities to ensure 
that the United States pursues 
well-coordinated 
and 
effective
drug control at all levels of gov-
ernment; 
‘‘(vii) such statistical data and 
information 
as 
the 
Director 
deems 
appropriate 
to 
dem-
onstrate and assess trends relat-
ing to illicit drug use, the effects 
and consequences thereof, supply 
reduction, 
demand 
reduction, 
drug-related 
law 
enforcement, 
and the implementation of the 
National Drug Control Strategy; 
and 
‘‘(viii) a supplement reviewing 
the activities of each individual 
National Drug Control Program 
agency during the previous year 
with respect to the National Drug 
Control Strategy and the Direc-
tor’s assessment of the progress of 
each National Drug Control Pro-
gram agency in meeting its re-
sponsibilities under the National 
Drug Control Strategy.
‘‘(B) 
CLASSIFIED
INFORMATION.—
Any contents of the National Drug 
Control Strategy that involve infor-
mation properly classified under cri-
teria established by an Executive 
order shall be presented to Congress 
separately from the rest of the Na-
tional Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFOR-
MATION.—In selecting data and infor-
mation for inclusion under subpara-
graph (A), the Director shall ensure—
‘‘(i) the inclusion of data and 
information that will permit anal-
ysis of current trends against pre-
viously compiled data and infor-
mation where the Director be-
lieves 
such 
analysis 
enhances 
long-term assessment of the Na-
tional Drug Control Strategy; and 
‘‘(ii) the inclusion of data and 
information to permit a standard-
ized and uniform assessment of 
the effectiveness of drug treat-
ment programs in the United 
States. 
‘‘(3) PROCESS
FOR
DEVELOPMENT
AND 
SUBMISSION.—
‘‘(A) 
CONSULTATION.—In 
devel-
oping and effectively implementing 
the National Drug Control Strategy, 
the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the Na-
tional Drug Control Program 
agencies; 
‘‘(II) Congress; 
‘‘(III) State and local offi-
cials; 
‘‘(IV) private citizens and 
organizations with experience 
and expertise in demand re-
duction; 
‘‘(V) private citizens and 
organizations with experience 
and expertise in supply reduc-
tion; 
‘‘(VI) private citizens and 
organizations with experience
and expertise in law enforce-
ment; and 
‘‘(VII) 
appropriate 
rep-
resentatives of foreign gov-
ernments; 
‘‘(ii) with the concurrence of 
the Attorney General, may re-
quire the El Paso Intelligence 
Center 
to 
undertake 
specific 
tasks or projects to implement the 
National Drug Control Strategy; 
‘‘(iii) with the concurrence of 
the Director of Central Intel-
ligence and the Attorney General, 
may request that the National 
Drug Intelligence Center under-
take specific tasks or projects to 
implement 
the 
National 
Drug 
Control Strategy; and 
‘‘(iv) may make recommenda-
tions to the Secretary of Health 
and Human Services on research 
that supports or advances the Na-
tional Drug Control Strategy.
‘‘(B) 
RECOMMENDATIONS.—Rec-
ommendations under subparagraph 
(A)(iv) may include recommendations 
of research to be performed at the 
National Institutes of Health, includ-
ing the National Institute on Drug 
Abuse, or any other appropriate agen-
cy within the Department of Health 
and Human Services. 
‘‘(C) INCLUSION IN STRATEGY.—The 
National 
Drug 
Control 
Strategy 
under this subsection shall include a 
list of each entity consulted under 
subparagraph (A)(i). 
‘‘(4) SUBMISSION
OF
REVISED
STRAT-
EGY.—The President may submit to Con-
gress a revised National Drug Control 
Strategy that meets the requirements of 
this section—
‘‘(A) at any time, upon a deter-
mination by the President, in con-
sultation with the Director, that the 
National Drug Control Strategy in ef-
fect is not sufficiently effective; or
‘‘(B) if a new President or Direc-
tor takes office. 
‘‘(b) 
PERFORMANCE
MEASUREMENT
SYS-
TEM.—Not later than February 1 of each year, 
the Director shall submit to Congress a de-
scription of the national drug control per-
formance measurement system, designed in 
consultation with affected National Drug Con-
trol Program agencies, that includes perform-
ance measures for the National Drug Control 
Strategy and activities of National Drug Con-
trol Program agencies related to the National 
Drug Control Strategy.’’. 
SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
(a) IN GENERAL.—Section 707 (21 U.S.C. 
1706) is amended to read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.—There is established 
in the Office a program to be known as the 
High Intensity Drug Trafficking Areas Pro-
gram (in this section referred to as the ‘Pro-
gram’).
‘‘(b) PURPOSES.—The purposes of the Pro-
gram are the following: 
‘‘(1) To reduce drug availability and 
facilitate 
cooperative 
efforts 
between 
Federal, State, and local law enforcement 
agencies in areas with significant drug 
trafficking problems that harmfully im-
pact other parts of the Nation. 
‘‘(2) To provide assistance to agencies 
to come together to assess regional 
threats, design coordinated strategies to 
combat those threats, share intelligence, 
and develop and implement coordinated 
initiatives to implement the strategies. 
‘‘(c) DESIGNATION.—The Director, upon 
consultation with the Attorney General, the 
Secretary of the Treasury, the Secretary of 
Homeland Security, heads of the National 
Drug Control Program agencies, and the Gov-
ernor of each applicable State, may designate 
any specified area of the United States as a 
high intensity drug trafficking area. 
‘‘(d) FACTORS FOR CONSIDERATION.—
‘‘(1) 
IN
GENERAL.—In 
considering 
whether to designate an area under this
section as a high intensity drug traf-
ficking area, the Director shall consider, 
in addition to such other criteria as the 
Director considers to be appropriate, the 
extent to which—
‘‘(A) the area is a major center of 
illegal 
drug 
production, 
manufac-
turing, importation, or distribution 
for the United States as compared to 
other areas of the United States; 
‘‘(B) State and local law enforce-
ment agencies have committed re-
sources to respond to the drug traf-
ficking problem in the area, thereby 
indicating a determination to re-
spond aggressively to the problem; 
‘‘(C) 
drug-related 
production, 
manufacturing, importation, or dis-
tribution in the area is having a sig-
nificant harmful impact in other 
areas of the United States; and 
‘‘(D) a significant increase in allo-
cation of Federal resources is nec-
essary to respond adequately to drug-
related activities in the area.
‘‘(2) CONSIDERATIONS.—For purposes 
of 
paragraph 
(1)(A), 
in 
considering 
whether an area is a major center of ille-
gal drug production, manufacturing, im-
portation, or distribution as compared to 
other areas of the United States, the Di-
rector shall consider—
‘‘(A) the quantity of illicit drug 
traffic entering or transiting the area 
originating in foreign countries; 
‘‘(B) the quantity of illicit drugs 
produced in the area; 
‘‘(C) the number of Federal, State, 
and local arrests, prosecutions, and 
convictions for drug trafficking and 
distribution offenses in the area; 
‘‘(D) the degree to which the area 
is a center for the activities of na-
tional drug trafficking organizations; 
and 
‘‘(E) such other criteria as the Di-
rector considers appropriate. 
‘‘(e) SOUTHWEST
BORDER.—The Director 
may not designate any county contiguous to 
the international land border with Mexico as
part of any high intensity drug trafficking 
area other than as part of a single Southwest 
Border high intensity drug trafficking area. 
‘‘(f) REMOVAL FROM DESIGNATION.—The Di-
rector may remove an area or portion of an 
area from designation as a high intensity 
drug trafficking area under this section upon 
determination that the area or portion of an 
area no longer is a high intensity drug traf-
ficking area, considering the factors in sub-
sections (d) and (e) in addition to such other 
criteria as the Director considers to be appro-
priate. 
‘‘(g) AUTHORITY
OF
THE DIRECTOR.—After 
making such a designation and in order to 
provide Federal assistance to the area so des-
ignated, the Director may—
‘‘(1) obligate such sums as appro-
priated for the Program; 
‘‘(2) direct the temporary reassign-
ment of Federal personnel to such area, 
subject to the approval of the head of the 
department or agency that employs such 
personnel; and
‘‘(3) take any other action authorized 
under section 704 to provide increased 
Federal assistance to those areas. 
‘‘(h) USE OF FUNDS.—
‘‘(1) 
LIMITATION.—No 
funds 
appro-
priated for the Program shall be ex-
pended for drug prevention or drug 
treatment programs. 
‘‘(2) LIMITATION
ON
APPLICABILITY.—
Paragraph (1) shall not apply with re-
spect to the Baltimore/Washington high 
intensity drug trafficking area. 
‘‘(i) TERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE AUTHORIZED.—The Di-
rector may authorize use of resources 
available for the Program to assist Fed-
eral, State, and local law enforcement 
agencies in investigations and activities 
related to terrorism and prevention of 
terrorism, especially but not exclusively 
where such investigations are related to 
drug trafficking. 
‘‘(2) LIMITATION.—The Director shall 
ensure—
‘‘(A) 
that 
assistance 
provided 
under paragraph (1) remains inci-
dental to the purpose of the Program 
to reduce drug availability and carry 
out drug-related law enforcement ac-
tivities; and 
‘‘(B) that significant resources of 
the Program are not redirected to ac-
tivities exclusively related to ter-
rorism. 
‘‘(j) BOARD REPRESENTATION.—None of the 
funds appropriated under this section may be 
expended for any high intensity drug traf-
ficking area, or for a partnership under the 
Program, if the executive board or equivalent 
governing committee with respect to such 
area or partnership is not comprised of equal 
voting representation between representa-
tives of Federal law enforcement agencies and 
representatives of State and local law en-
forcement agencies. 
‘‘(k) ROLE OF DRUG ENFORCEMENT ADMINIS-
TRATION.—The Director, in consultation with 
the Attorney General, shall ensure that a rep-
resentative of the Drug Enforcement Adminis-
tration is included in the Intelligence Support 
Center for each high intensity drug traf-
ficking area. 
‘‘(l) AUTHORIZATION OF APPROPRIATIONS.—
There is authorized to be appropriated to the 
Office of National Drug Control Policy to 
carry out this section—
‘‘(1) $230,000,000 for fiscal year 2004; 
‘‘(2) $240,000,000 for each of fiscal 
years 2005 and 2006; and 
‘‘(3) $250,000,000 for each of fiscal 
years 2007 and 2008.’’. 
(b) REVIEW
OF CURRENT AREAS.—Within 
one year after the date of enactment of this 
Act, the Director of National Drug Control 
Policy shall—
(1) review each of the areas currently 
designated as a high intensity drug traf-
ficking area to determine whether it con-
tinues to warrant designation as a high 
intensity drug trafficking area, consid-
ering the factors in section 707(d) of the 
Office of National Drug Control Policy 
Reauthorization Act of 1998, as amended 
by this section, in addition to such other
criteria as the Director considers to be 
appropriate; and 
(2) terminate such description for an 
area or portion of an area determined to 
no longer warrant designation. 
SEC. 7. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be 
cited as the ‘‘Dawson Family Community Pro-
tection Act’’. 
(b) FINDINGS.—Congress finds the fol-
lowing: 
(1) In the early morning hours of Oc-
tober 16, 2002, the home of Carnell and 
Angela Dawson was firebombed in appar-
ent retaliation for Mrs. Dawson’s notifica-
tion of police about persistent drug dis-
tribution activity in their East Baltimore 
City neighborhood. 
(2) The arson claimed the lives of Mr. 
and Mrs. Dawson and their 5 young chil-
dren, aged 9 to 14. 
(3) The horrific murder of the Daw-
son family is a stark example of domestic 
narco-terrorism.
(4) In all phases of counter-narcotics 
law enforcement—from prevention to in-
vestigation to prosecution to reentry—the 
voluntary cooperation of ordinary citi-
zens is a critical component. 
(5) Voluntary cooperation is difficult 
for law enforcement officials to obtain 
when citizens feel that cooperation car-
ries the risk of violent retaliation by ille-
gal drug trafficking organizations and 
their affiliates. 
(6) Public confidence that law en-
forcement is doing all it can to make 
communities safe is a prerequisite for 
voluntary cooperation among people who 
may be subject to intimidation or reprisal 
(or both). 
(7) Witness protection programs are 
insufficient on their own to provide secu-
rity because many individuals and fami-
lies who strive every day to make dis-
tressed neighborhoods livable for their 
children, other relatives, and neighbors 
will resist or refuse offers of relocation 
by local, State, and Federal prosecutorial
agencies and because, moreover, the con-
tinued presence of strong individuals and 
families is critical to preserving and 
strengthening the social fabric in such 
communities. 
(8) Where (as in certain sections of 
Baltimore City) interstate trafficking of 
illegal drugs has severe ancillary local 
consequences within areas designated as 
high intensity drug trafficking areas, it is 
important that supplementary High In-
tensity Drug Trafficking Areas Program 
funds be committed to support initiatives 
aimed at making the affected commu-
nities safe for the residents of those com-
munities and encouraging their coopera-
tion with local, State, and Federal law en-
forcement efforts to combat illegal drug 
trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY 
DRUG TRAFFICKING AREAS.—Section 707 (21 
U.S.C. 1706) is further amended in subsection 
(h) by adding at the end the following new 
paragraph: 
‘‘(3) SPECIFIC PURPOSES.—
‘‘(A) IN
GENERAL.—The Director 
shall ensure that, of the amounts ap-
propriated for a fiscal year for the 
Program, at least $1,000,000 is used in 
high intensity drug trafficking areas 
with severe neighborhood safety and 
illegal drug distribution problems. 
‘‘(B) REQUIRED
USES.—The funds 
used under subparagraph (A) shall be 
used—
‘‘(i) to ensure the safety of 
neighborhoods and the protection 
of 
communities, 
including 
the 
prevention of the intimidation of 
potential witnesses of illegal drug 
distribution and related activi-
ties; and 
‘‘(ii) to combat illegal drug 
trafficking through such methods 
as the Director considers appro-
priate, such as establishing or op-
erating (or both) a toll-free tele-
phone hotline for use by the pub-
lic to provide information about 
illegal drug-related activities.’’.
SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH-
NOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 
U.S.C. 1707(b)) is amended—
(1) in the heading by striking ‘‘DIREC-
TOR
OF
TECHNOLOGY.—’’ and inserting 
‘‘CHIEF SCIENTIST.—’’; and 
(2) by striking ‘‘Director of Tech-
nology,’’ and inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIREC-
TOR.—Section 708(c) (21 U.S.C. 1707(c)) is 
amended to read as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE 
DIRECTOR
OF NATIONAL DRUG CONTROL POL-
ICY.—
‘‘(1) IN GENERAL.—The Director, acting 
through the Chief Scientist, shall—
‘‘(A) identify and define the short-
, medium-, and long-term scientific 
and technological needs of Federal, 
State, and local law enforcement 
agencies relating to drug enforce-
ment, including—
‘‘(i) 
advanced 
surveillance, 
tracking, and radar imaging;
tration, and through interagency 
agreements or grants, examining 
addiction and rehabilitation re-
search and the application of 
technology to expanding the ef-
fectiveness or availability of drug 
treatment; 
‘‘(C) make a priority ranking of 
such needs identified in subpara-
graphs (A) and (B) according to fiscal 
and technological feasibility, as part 
of a National Counter-Drug Enforce-
ment Research and Development Pro-
gram; 
‘‘(D) 
oversee 
and 
coordinate 
counter-drug technology initiatives 
with related activities of other Fed-
eral civilian and military depart-
ments; 
‘‘(E) oversee and coordinate a 
technology transfer program for the 
transfer of technology to State and 
local law enforcement agencies; and 
‘‘(F) pursuant to the authority of 
the Director of National Drug Control
Policy under section 704, submit re-
quests to Congress for the reprogram-
ming or transfer of funds appro-
priated for counter-drug technology 
research and development. 
‘‘(2) PRIORITIES IN TRANSFERRING TECH-
NOLOGY.—In 
transferring 
technology 
under the authority of paragraph (1)(E), 
the Chief Scientist shall give priority, in 
transferring technologies most likely to 
assist in drug interdiction and border en-
forcement, to State, local, and tribal law 
enforcement agencies in southwest bor-
der areas and northern border areas with 
significant traffic in illicit drugs. 
‘‘(3) LIMITATION
ON
AUTHORITY.—The 
authority granted to the Director under 
this subsection shall not extend to the 
award of contracts, management of indi-
vidual projects, or other operational ac-
tivities.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOME-
LAND
SECURITY.—Section 708(d) (21 U.S.C. 
1707(d)) is amended by inserting ‘‘, the Sec-
retary of Homeland Security,’’ after ‘‘The Sec-
retary of Defense’’. 
SEC. 9. REPEALS. 
The following provisions are repealed: 
(1) Sections 709 and 711 (21 U.S.C. 
1708 and 1710). 
(2) Section 6073 of the Asset For-
feiture Amendments Act of 1988 (21 U.S.C. 
1509). 
SEC. 10. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN
GENERAL.—The Act is further 
amended by inserting after section 708 (21 
U.S.C. 1707) the following: 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall con-
duct a national media campaign in accord-
ance with this section for the purpose of re-
ducing and preventing illicit drug use among 
young people in the United States, through 
mass media advertising. 
‘‘(b) USE OF FUNDS.—
‘‘(1) 
IN
GENERAL.—Amounts 
made 
available to carry out this section for the 
media campaign may only be used for the 
following:
‘‘(A) The purchase of media time 
and space. 
‘‘(B) Creative and talent costs. 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of ad-
vertising. 
‘‘(E) Evaluation of the effective-
ness of the media campaign. 
‘‘(F) The negotiated fees for the 
winning bidder on requests for pro-
posals issued either by the Office or 
its designee for purposes otherwise 
authorized in this section. 
‘‘(G) Partnerships with commu-
nity, civic, and professional groups 
and government organizations re-
lated to the media campaign. 
‘‘(H) Entertainment industry out-
reach, interactive outreach, media 
projects and activities, public infor-
mation, news media outreach, and 
corporate sponsorship and participa-
tion. 
‘‘(I) Operational and management 
expenses.
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for cre-
ative and talent costs under para-
graph (1)(B), the Director shall 
use creative services donated at 
no cost to the Government wher-
ever feasible and may only pro-
cure creative services for adver-
tising—
‘‘(I) responding to high-
priority or emergent media 
campaign needs that cannot 
timely be obtained at no cost; 
or 
‘‘(II) intended to reach a 
minority, ethnic, or other spe-
cial audience that cannot rea-
sonably be obtained at no 
cost. 
‘‘(ii) No more than $1,000,000 
may be expended under this sec-
tion each fiscal year on creative 
services, except that the Director 
may expend up to $2,000,000 in a
fiscal year on creative services to 
meet urgent needs of the media 
campaign with advance approval 
from the Committees on Appro-
priations of the House of Rep-
resentatives and of the Senate 
upon 
a 
showing 
of 
the 
cir-
cumstances causing such urgent 
needs of the media campaign. 
‘‘(B) TESTING
AND
EVALUATION
OF 
ADVERTISING.—In using amounts for 
testing and evaluation of advertising 
under paragraph (1)(D), the Director 
shall test all advertisements prior to 
use in the media campaign to ensure 
that the advertisements are effective 
and meet industry-accepted stand-
ards. The Director may waive this re-
quirement for advertisements using 
no more than 10 percent of the pur-
chase of advertising time purchased 
under this section in a fiscal year and 
no more than 10 percent of the adver-
tising space purchased under this 
section in a fiscal year, if the adver-